Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
QTRX
QTRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
QTRX News
Quanterix (QTRX) Q4 2025 Earnings Call Transcript
Mar 03 2026
NASDAQ.COM
Quanterix Corporation Q4 2025 Earnings Call Insights
Mar 03 2026
seekingalpha
Quanterix Q4 Earnings Beat Expectations Despite EPS Miss
Mar 02 2026
seekingalpha
Lucent Diagnostics Partners with Life Line Screening for National Testing
Mar 02 2026
Businesswire
Lucent Diagnostics Partners with Life Line Screening to Enhance Disease Detection
Mar 02 2026
Newsfilter
Quanterix Set to Announce Q4 Earnings on March 2nd
Mar 01 2026
seekingalpha
Quanterix Corporation to Participate in Investor Conferences
Feb 26 2026
Newsfilter
Quanterix to Host Conference Call for 2025 Financial Results
Feb 20 2026
Businesswire
Quanterix to Host Q4 2025 Financial Results Conference Call on March 2, 2026
Feb 20 2026
Newsfilter
Quanterix Submits Blood Test for Alzheimer's Disease to FDA
Feb 03 2026
Newsfilter
Quanterix Publishes Landmark Alzheimer’s Study with C-Index of 0.90
Jan 21 2026
Businesswire
Rich Sparkle Holdings Signs $39 Million Share Offering Agreement
Jan 09 2026
Benzinga
CG Oncology Accelerates Phase 3 Data Readout to First Half of 2026
Jan 09 2026
Benzinga
Quanterix Appoints Everett Cunningham as New CEO Effective January 19, 2026
Jan 08 2026
Businesswire
Quanterix Unveils Leadership and Board Changes to Facilitate Future Growth
Nov 20 2025
Newsfilter
Quanterix Unveils Pioneering Study Showcasing Dual GFAP/NfL Blood Test Method for Tailored Monitoring of Multiple Sclerosis
Nov 17 2025
Newsfilter
Show More News
